Citation: Y. Liang et Ah. Cincotta, Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice, INT J OBES, 25(5), 2001, pp. 698-704
Citation: Tl. Jetton et al., Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice, METABOLISM, 50(11), 2001, pp. 1377-1384
Citation: Kz. Kraszewski et Ah. Cincotta, Increased responsiveness of ventromedial hypothalamic neurons to norepinephrine in obese versus lean mice: Relation to the metabolic syndrome, INT J MOL M, 5(4), 2000, pp. 349-355
Citation: Ah. Cincotta et al., Hyperinsulinemia increases norepinephrine metabolism in the ventromedial hypothalamus of rats, NEUROREPORT, 11(2), 2000, pp. 383-387
Citation: Sq. Luo et al., Association of the antidiabetic effects of bromocriptine with a shift in the daily rhythm of monoamine metabolism within the suprachiasmatic nuclei of the Syrian hamster, CHRONOBIO I, 17(2), 2000, pp. 155-172
Citation: Va. Boundy et Ah. Cincotta, Hypothalamic adrenergic receptor changes in the metabolic syndrome of genetically obese (ob/ob) mice, AM J P-REG, 279(2), 2000, pp. R505-R514
Authors:
Cincotta, AH
Luo, SQ
Zhang, Y
Liang, Y
Bina, KG
Jetton, TL
Scislowski, PWD
Citation: Ah. Cincotta et al., Chronic infusion of norepinephrine into the VMH of normal rats induces theobese glucose-intolerant state, AM J P-REG, 278(2), 2000, pp. R435-R444
Citation: Kg. Bina et Ah. Cincotta, Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice, NEUROENDOCR, 71(1), 2000, pp. 68-78
Citation: Sq. Luo et al., Suprachiasmatic nuclei monoamine metabolism of glucose tolerant versus intolerant hamsters, NEUROREPORT, 10(10), 1999, pp. 2073-2077
Authors:
Keisari, Y
Cincotta, E
Meier, AH
Cincotta, AH
Citation: Y. Keisari et al., Timed daily administration of prolactin and corticosteroid hormone reducesmurine tumor growth and enhances immune reactivity, CHRONOBIO I, 16(3), 1999, pp. 315-333
Authors:
Scislowski, PWD
Tozzo, E
Zhang, Y
Phaneuf, S
Prevelige, R
Cincotta, AH
Citation: Pwd. Scislowski et al., Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in ob/ob mice treated with dopaminergic agonists, INT J OBES, 23(4), 1999, pp. 425-431
Authors:
Hendrzak-Henion, JA
Knisely, TL
Cincotta, L
Cincotta, E
Cincotta, AH
Citation: Ja. Hendrzak-henion et al., Role of the immune system in mediating the antitumor effect of benzophenothiazine photodynamic therapy, PHOTOCHEM P, 69(5), 1999, pp. 575-581
Citation: Sq. Luo et al., Chronic ventromedial hypothalamic infusion of norepinephrine and serotoninpromotes insulin resistance and glucose intolerance, NEUROENDOCR, 70(6), 1999, pp. 460-465
Citation: Sq. Luo et al., Intracerebroventricular administration of bromocriptine ameliorates the insulin-resistant/glucose-intolerant state in hamsters, NEUROENDOCR, 69(3), 1999, pp. 160-166
Citation: Y. Liang et al., Long-term infusion of norepinephrine plus serotonin into the ventromedial hypothalamus impairs pancreatic islet function, METABOLISM, 48(10), 1999, pp. 1287-1289